# Sermorelin FAQ: GHRH(1-29) Questions Answered From the Research Record

> Sermorelin FAQ — direct, cited answers on mechanism, comparisons with ipamorelin, CJC-1295, and tesamorelin, IGF-1, sleep, cognition, side effects, and timing, drawn from the published literature.

Twenty-two questions on GHRH(1-29) — mechanism, comparisons, IGF-1, sleep, cognition, safety, and timing — each answer direct and cited.

## How does sermorelin compare to CJC-1295?

Both stimulate the GHRH receptor, but native sermorelin (GHRH(1-29)) is rapidly cleared, whereas CJC-1295 is a long-acting analogue that produced prolonged GH and IGF-1 elevation over days in healthy adults [15]. D-Ala2 substitution and DAC technology extend the short action of the native peptide [17]. Same target, engineered for a longer reach.

## Sermorelin vs ipamorelin: what is the difference?

Sermorelin is a GHRH analogue acting on the pituitary GHRH receptor; ipamorelin is a selective growth-hormone-releasing peptide (GHRP) acting on the ghrelin/GHS receptor without significant ACTH, cortisol, or prolactin effects [16]. It is a different mechanism in the same secretagogue family — the same destination through a different receptor.

## Does sermorelin affect testosterone?

Sermorelin acts on the GH/IGF-1 axis, not the gonadal axis. Growth-hormone-secretagogue treatment in hypogonadal men raised serum IGF-1 [21], and secretagogues appear in men's-health body-composition research, but the studies describe IGF-1 rather than a direct testosterone effect. The two hormonal systems are distinct.

## How does sermorelin differ from direct HGH injections?

Sermorelin acts upstream on the pituitary to stimulate the body's own pulsatile GH release with somatostatin and IGF-1 feedback intact, rather than supplying exogenous GH. An editorial argued this physiologic secretagogue approach may be more physiologic than recombinant GH for adult-onset GH insufficiency [4]. Direct GH injection bypasses the pituitary; sermorelin works through it.

## Sermorelin vs tesamorelin: how do they differ?

Both are GHRH analogues; tesamorelin is a stabilized, longer-acting analogue that is FDA-approved for HIV-associated lipodystrophy and reduced visceral adipose tissue versus placebo [18], while sermorelin is the native GHRH(1-29) fragment, formerly approved for pediatric GH deficiency and now compounded.

## What pairs well with sermorelin (e.g., ipamorelin or GHRP-2)?

Research-user discussions often pair a GHRH analogue with a GHRP because the two act on different receptors. The record characterizes ipamorelin as a selective GHRP [16] but reports no clinical combination trial of sermorelin, so this is described as a mechanistic rationale, not an established protocol.

## What is sermorelin?

Sermorelin (sermorelin acetate) is a synthetic, amidated 29-amino-acid peptide corresponding to the GHRH(1-29) fragment of growth-hormone-releasing hormone — the shortest fragment retaining full GHRH-receptor activity — studied as a pituitary growth-hormone secretagogue [7].

## What does sermorelin do to the body?

It binds GHRH receptors on anterior-pituitary somatotrophs, activating the cAMP/PKA pathway to stimulate synthesis and pulsatile release of the body's own growth hormone and, downstream, hepatic IGF-1, while somatostatin and IGF-1 feedback remain intact [2][4].

## Does sermorelin work?

In its approved pediatric setting, once-daily subcutaneous GHRH(1-29) accelerated linear growth in GH-deficient children [1]; in older men, 14 days of dosing reversed age-related declines in GH and IGF-1 [2]. Authorities caution that secretagogue use for aging is not yet established [5].

## How long does it take for sermorelin to work?

Pharmacology shows GH rises within hours of a dose and stays elevated about 3 hours despite rapid clearance [3]; measurable IGF-1 and body-composition changes in trials were reported over weeks — for example 14 days in older men [2] and 20 weeks in the cognition trial [6].

## What is sermorelin used for?

Sermorelin was FDA-approved for evaluating and treating growth-hormone deficiency / short stature in children, and has been studied in research on the aging GH/IGF-1 axis, body composition, sleep, and cognition. It is now prepared by compounding pharmacies and supplied as a research peptide for laboratory study.

## Does sermorelin actually help with sleep, or is it waking me up instead?

GHRH had sleep-promoting (slow-wave) effects in normal men [22], but its sleep-endocrine effect depends on the time of administration [12] and is reduced in the elderly [13] — so the literature describes a circadian-dependent, age-sensitive effect rather than a uniform one.

## Why is it recommended to inject sermorelin at night?

Slow-wave sleep coincides with the body's largest nocturnal GH pulse [14], and bedtime dosing in the research literature was used to align GHRH stimulation with that natural nighttime release; GHRH's sleep-endocrine effect is itself time-of-day dependent [12].

## Does sermorelin burn fat?

GHRH-axis stimulation can change body composition: the stabilized analogue tesamorelin reduced visceral adipose tissue versus placebo [18], and the cognition trial reported a 7.4% reduction in percent body fat [6]. These are drug-class GHRH-analogue findings, presented factually rather than as a proven sermorelin fat-loss claim.

## Is sermorelin effective for weight loss?

The literature reports body-composition effects (reduced visceral fat, reduced percent body fat) in GHRH-analogue trials [18][6], but these are not the same as a validated weight-loss indication for sermorelin; anti-aging and body-composition marketing outpaces the rigorous long-term evidence [5].

## Will sermorelin raise my IGF-1 levels?

Raising IGF-1 is a central, well-documented effect of GHRH-axis stimulation: 14 days of GHRH(1-29) increased 24-hour GH and IGF-1 dose-dependently in older men [2], and a GHRH analogue raised IGF-1 by 117% within the physiologic range in a 20-week trial [6].

## Does sermorelin build muscle?

The record does not contain a sermorelin muscle-hypertrophy trial; it links GHRH-axis stimulation to IGF-1 elevation [2] and body-composition change [6], and reviews discuss GH/IGF-1 modulation as a candidate strategy against age-related muscle loss (sarcopenia) — candidate rationale, not proven muscle-building.

## Does sermorelin affect the brain?

GHRH administration modulated brain GABA levels in mild cognitive impairment and healthy aging [23] and had a favorable effect on cognition in a randomized trial [6]; these neuroendocrine effects were observed with GHRH-analogue dosing in older adults.

## Can sermorelin or GHRH improve cognition in older adults?

In a randomized, double-blind, placebo-controlled trial of 152 older adults (66 with mild cognitive impairment), 20 weeks of a GHRH analogue had a favorable effect on cognition (P=0.03) [6], with an earlier controlled study also reporting improved cognition in healthy older adults [24].

## What are the side effects of sermorelin?

Reported effects in studies were generally mild: injection-site reactions [9], reversible GHRH antibodies that did not affect growth [10][26], and transient hyperlipidemia that resolved [25]; mild glucose-tolerance impairment was seen in elderly subjects on repeated dosing [9]. Long-term adult anti-aging safety data remain limited [5].

## When is the best time to take sermorelin?

Research protocols commonly used bedtime dosing because GHRH's sleep-endocrine effect is time-of-day dependent [12] and slow-wave sleep coincides with nocturnal GH release [14]; this is a description of study design, not a dosing recommendation.

## Is 3 months of sermorelin enough?

Study durations varied widely: 14 days reversed GH/IGF-1 declines in older men [2], 16 weeks of nightly dosing activated the somatotropic axis [25], and pediatric height-velocity benefit was measured over the first year [1]. The literature reports outcomes by study length rather than endorsing a fixed course.

---

A soft control board of the sermorelin literature — every GHRH(1-29) finding pressed into its own lit module and wired back to its study, the confirmed pediatric result and the unsettled adult anti-aging gap kept on separate panels; no clinic behind the console and nothing here compounded, prescribed, or sold.